| 0 |
ACQUIRED HAEMOGLOBINOPATHY |
1 |
0.2000 |
| 1 |
CRYOTHERAPY |
1 |
0.0135 |
| 2 |
TESTICULAR FAILURE |
1 |
0.0073 |
| 3 |
POSITIVE AIRWAY PRESSURE THERAPY |
1 |
0.0034 |
| 4 |
LACK OF ADMINISTRATION SITE ROTATION |
1 |
0.0033 |
| 5 |
TONGUE EXFOLIATION |
1 |
0.0028 |
| 6 |
TOTAL LUNG CAPACITY ABNORMAL |
1 |
0.0026 |
| 7 |
FACTOR V LEIDEN MUTATION |
1 |
0.0025 |
| 8 |
HUMAN PAPILLOMA VIRUS TEST POSITIVE |
1 |
0.0025 |
| 9 |
LOCAL REACTION |
1 |
0.0013 |
| 10 |
LIP ERYTHEMA |
1 |
0.0013 |
| 11 |
TUMOUR EXCISION |
1 |
0.0012 |
| 12 |
TONGUE ERYTHEMA |
1 |
0.0012 |
| 13 |
APTYALISM |
1 |
0.0012 |
| 14 |
INTERCEPTED PRODUCT STORAGE ERROR |
3 |
0.0008 |
| 15 |
SEROMA |
1 |
0.0008 |
| 16 |
DACRYOSTENOSIS ACQUIRED |
1 |
0.0008 |
| 17 |
TUMOUR PAIN |
1 |
0.0008 |
| 18 |
NORMOCYTIC ANAEMIA |
1 |
0.0007 |
| 19 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 20 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
3 |
0.0006 |
| 21 |
PLEURITIC PAIN |
1 |
0.0004 |
| 22 |
ACNE CYSTIC |
1 |
0.0003 |
| 23 |
BREAST CANCER RECURRENT |
1 |
0.0003 |
| 24 |
WOUND DEHISCENCE |
1 |
0.0003 |
| 25 |
THROMBOCYTOSIS |
1 |
0.0003 |
| 26 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 27 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 28 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
4 |
0.0002 |
| 29 |
PHLEBITIS |
1 |
0.0002 |
| 30 |
SENSITIVITY TO WEATHER CHANGE |
1 |
0.0002 |
| 31 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 32 |
HYPERCHLORHYDRIA |
1 |
0.0002 |
| 33 |
NO ADVERSE EVENT |
30 |
0.0002 |
| 34 |
INCOHERENT |
1 |
0.0002 |
| 35 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
1 |
0.0001 |
| 36 |
LYMPHOEDEMA |
1 |
0.0001 |
| 37 |
FORMICATION |
1 |
0.0001 |
| 38 |
TONGUE DISORDER |
1 |
0.0001 |
| 39 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 40 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 41 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 42 |
HYSTERECTOMY |
1 |
0.0001 |
| 43 |
NAIL DISORDER |
1 |
0.0001 |
| 44 |
EXOSTOSIS |
1 |
0.0001 |
| 45 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 46 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 47 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 48 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 49 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 50 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
| 51 |
PRODUCT STORAGE ERROR |
7 |
0.0001 |
| 52 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 53 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 54 |
HIATUS HERNIA |
1 |
0.0001 |
| 55 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 56 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 57 |
HYPOACUSIS |
3 |
0.0001 |
| 58 |
STOMATITIS |
4 |
0.0001 |
| 59 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 60 |
OBESITY |
1 |
0.0001 |
| 61 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 62 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 63 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 64 |
NEUROPATHY PERIPHERAL |
5 |
0.0001 |
| 65 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 66 |
SINUS DISORDER |
1 |
0.0001 |
| 67 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 68 |
TASTE DISORDER |
1 |
0.0000 |
| 69 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 70 |
EATING DISORDER |
1 |
0.0000 |
| 71 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 72 |
INTENTIONAL PRODUCT USE ISSUE |
4 |
0.0000 |
| 73 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 74 |
HEPATOTOXICITY |
1 |
0.0000 |
| 75 |
GLOSSODYNIA |
1 |
0.0000 |
| 76 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 77 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 78 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 79 |
PRESYNCOPE |
1 |
0.0000 |
| 80 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 81 |
HAEMATOMA |
1 |
0.0000 |
| 82 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 83 |
ASCITES |
1 |
0.0000 |
| 84 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 85 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 86 |
IMPAIRED HEALING |
1 |
0.0000 |
| 87 |
SKIN DISORDER |
1 |
0.0000 |
| 88 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 89 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 90 |
EPISTAXIS |
2 |
0.0000 |
| 91 |
COLITIS |
1 |
0.0000 |
| 92 |
OFF LABEL USE |
23 |
0.0000 |
| 93 |
INJECTION SITE PAIN |
8 |
0.0000 |
| 94 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 95 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 96 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 97 |
SWELLING |
2 |
0.0000 |
| 98 |
CONTUSION |
2 |
0.0000 |
| 99 |
LUNG DISORDER |
1 |
0.0000 |
| 100 |
LEUKOPENIA |
1 |
0.0000 |
| 101 |
FLUSHING |
2 |
0.0000 |
| 102 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 103 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 104 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 105 |
MEDICATION ERROR |
1 |
0.0000 |
| 106 |
ASTHMA |
2 |
0.0000 |
| 107 |
BONE PAIN |
1 |
0.0000 |
| 108 |
NASAL CONGESTION |
1 |
0.0000 |
| 109 |
IRRITABILITY |
1 |
0.0000 |
| 110 |
DISCOMFORT |
1 |
0.0000 |
| 111 |
FEELING HOT |
1 |
0.0000 |
| 112 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 113 |
RHINORRHOEA |
1 |
0.0000 |
| 114 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 115 |
ALOPECIA |
3 |
0.0000 |
| 116 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 117 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 118 |
WEIGHT DECREASED |
4 |
0.0000 |
| 119 |
BURNING SENSATION |
1 |
0.0000 |
| 120 |
ACNE |
1 |
0.0000 |
| 121 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 122 |
DIABETES MELLITUS |
1 |
0.0000 |
| 123 |
DRY MOUTH |
1 |
0.0000 |
| 124 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 125 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 126 |
COVID-19 |
2 |
0.0000 |
| 127 |
DIARRHOEA |
7 |
0.0000 |
| 128 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 129 |
ANAEMIA |
2 |
0.0000 |
| 130 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 131 |
SYNCOPE |
1 |
0.0000 |
| 132 |
SOMNOLENCE |
2 |
0.0000 |
| 133 |
PAIN |
6 |
0.0000 |
| 134 |
ERYTHEMA |
2 |
0.0000 |
| 135 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 136 |
SEPSIS |
1 |
0.0000 |
| 137 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 138 |
DECREASED APPETITE |
2 |
0.0000 |
| 139 |
CHILLS |
1 |
0.0000 |
| 140 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 141 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 142 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 143 |
HYPERHIDROSIS |
1 |
0.0000 |
| 144 |
NAUSEA |
6 |
0.0000 |
| 145 |
INSOMNIA |
2 |
0.0000 |
| 146 |
VISION BLURRED |
1 |
0.0000 |
| 147 |
INFECTION |
1 |
0.0000 |
| 148 |
RASH |
3 |
0.0000 |
| 149 |
PARAESTHESIA |
1 |
0.0000 |
| 150 |
DRUG INTERACTION |
1 |
0.0000 |
| 151 |
URTICARIA |
1 |
0.0000 |
| 152 |
MYALGIA |
1 |
0.0000 |
| 153 |
CHEST PAIN |
1 |
0.0000 |
| 154 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 155 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 156 |
FATIGUE |
4 |
0.0000 |
| 157 |
HYPOTENSION |
1 |
0.0000 |
| 158 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 159 |
ARTHRALGIA |
2 |
0.0000 |
| 160 |
HYPERTENSION |
1 |
0.0000 |
| 161 |
DEATH |
4 |
0.0000 |
| 162 |
MALAISE |
2 |
0.0000 |
| 163 |
WEIGHT INCREASED |
1 |
0.0000 |
| 164 |
DEPRESSION |
1 |
0.0000 |
| 165 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 166 |
COUGH |
1 |
0.0000 |
| 167 |
DYSPNOEA |
2 |
0.0000 |
| 168 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 169 |
PYREXIA |
1 |
0.0000 |
| 170 |
ASTHENIA |
1 |
0.0000 |
| 171 |
PRURITUS |
1 |
0.0000 |
| 172 |
VOMITING |
1 |
0.0000 |
| 173 |
DIZZINESS |
1 |
0.0000 |
| 174 |
HEADACHE |
1 |
0.0000 |
| 175 |
DRUG INEFFECTIVE |
1 |
0.0000 |